Stocks · News reference
AvePoint (NASDAQ:AVPT) sees Q3 sales of $128.200 million-$130.200 million vs $133.613 million analyst estimate.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
AvePoint (NASDAQ:AVPT) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you by Benzinga
Analysts initiated coverage: MOD Outperform/$300, AVPT Outperform/$17, STDN Buy/$18, LMT Buy/$650, and ZGN Buy/$16.
BMO Capital analyst Keith Bachman initiates coverage on AvePoint (NASDAQ:AVPT) with a Outperform rating and announces Price Target of $17.
Stephens & Co. analyst Todd Weller maintains AvePoint (NASDAQ:AVPT) with a Overweight and raises the price target from $16 to $17.